Subscribed Libraries
Medical Medical Videos
| Department | Title | Author | Short Description | Video Url |
|---|---|---|---|---|
| DRUG DESIGN | Public Lecture—Mutant Ribosomes and the Action of Antibiotics | SLAC National Accelerator Laboratory | The ribosome, found in all living cells, is the molecular machine that builds proteins. | View |
| DRUG DESIGN | Drug Discovery: What’s the difference between structure based and ligand based virtual screening? | CCDCCambridge | Watch Abhik Mukhopadyay, Research and Applications Scientist at CCDC, to learn the difference between structure based and ligand based. | View |
| DRUG DESIGN | Structure Based Drug Discovery: Case study and Conclusion | IIT Roorkee July 2018 | This lecture covers a beautiful case study of designing a novel inhibitor against drug-resistant Mycobacterium tuberculosis beta-lactamase BlaC. | View |
| DRUG DESIGN | Structure based & Ligand based drug design : Basics & Advances | JSS Academy of Higher Education & Research | View | |
| DRUG DESIGN | Fredrik Rahm (Sprint Bioscience): Improving Workflows for Structure-Based Drug Design | ChemAxon | At Sprint Bioscience we use fragment-based techniques to quickly find high-quality chemical starting points for our small molecule drug discovery projects. | View |
| DRUG DESIGN | Schrödinger | SBGrid Consortium | Schrödinger Introduction to Structure-Based Drug Design | View |
| DRUG DESIGN | Pharmacophore-based virtual screening of pyridopyridazin-6-ones – Video abstract 50738 | Dove Medical Press | Video abstract of original research paper “Pharmacophore generation, atom-based 3D-QSAR, docking, and virtual screening studies of p38-α mitogen activated protein kinase inhibitors: pyridopyridazin-6-ones (part 2) | View |
| DRUG DESIGN | Jenny Viklund & Fredrik Rahm (Sprint Bioscience): Marvin Live for structure-based drug design | ChemAxon | How to make better molecules faster is a key challenge in preclinical drug discovery. | View |
| DRUG DESIGN | Structure Based Drug Design An Overview | Dr. Anwar R. Shaikh | Structure Based Drug Design An Overview | View |
| DRUG DESIGN | webinar recording: structure-based drug design of selective Drp1 inhibitors | BioSolveITTutorials | The mitochondrial protein dynamin-related protein (Drp1) has been implicated in the development of a number of diseases, including cancer, heart disease and dementia. To date, no direct small molecule inhibitors of human Drp1 have been identified. | View |
All Libraries
LOCKED